Scopus BioPharma Inc. (SCPS)
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -11.71M | -27.63M | -10.16M | -2.69M | -685.96K |
| Interest Income | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -11.71M | -26.95M | -10.86M | -2.69M | -685.96K |
| Net Income | -11.61M | -27.73M | -11.57M | -2.69M | -685.96K |
| Selling & General & Admin | 9.03M | 12.61M | 2.73M | 2.23M | 408.43K |
| Research & Development | 2.68M | 15.02M | 7.42M | 463.11K | 277.54K |
| Other Expenses | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 11.71M | 27.63M | 10.16M | 2.69M | 685.96K |
| Interest Expense | n/a | 774.68K | 706.45K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 11.71M | 27.63M | 10.16M | 2.69M | 685.96K |
| Income Tax | -105.05K | 774.68K | 706.45K | 1.00 | -847.11K |
| Shares Outstanding (Basic) | 21.09M | 17.25M | 13.36M | 14.98M | 14.98M |
| Shares Outstanding (Diluted) | 21.09M | 17.25M | 13.36M | 14.98M | 14.98M |
| EPS (Basic) | -0.55 | -1.61 | -0.87 | -0.18 | -0.05 |
| EPS (Diluted) | -0.55 | -1.61 | -0.87 | -0.18 | -0.05 |
| EBITDA | -11.71M | -27.63M | -10.15M | -2.69M | -685.96K |
| Depreciation & Amortization | 1.73K | 1.50K | 1.44K | 664.00 | 161.14K |